Evidence map›Paper›PMID 42350727›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Research progress on the expression characteristics, biological functions, and therapeutic potential of NOX4 in malignant tumors: a functional perspective.

Kaixiu Wu, Yue Yang, Meng Xu, Jiayan Guo, Ran Wang, Xinyan Tian, Yarong Hu, Xiaping He, Juan Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaixiu WuBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Yue YangBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Meng XuBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Jiayan GuoBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Ran WangBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Xinyan TianBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Yarong HuBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China.
Xiaping HeBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China. hxp0512@126.com.
Juan LiBasic Medical Sciences, Dali University, Yunnan Province, Dali City, 671013, China. juanjuannk@126.com.ORCID http://orcid.org/0009-0002-4508-4802

Funding

Basic Research Plan Project of Yunnan Science and Technology Department 202401AT071193Supported by the Special Basic Cooperative Research Programs of Yunnan Provincial Undergraduate Universities' Association 202401BA070001-072Yunnan Provincial Department of Education Young Talents Basic Research Project Special 2025J0769
6 · The paper itself

Abstract

Nicotinamide adenine dinucleotide phosphate oxidase 4, abbreviated as NOX4, is a constitutively active member of the NADPH oxidase family. It primarily produces hydrogen peroxide (H

Indexed as

Malignant tumorNOX4ROSSignaling pathwayTherapeutic targets

Identifiers

PMID42350727

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.